Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
05/1995
05/11/1995WO1995012394A1 Use of nitric oxide releasing compounds as protective agents in ischemia reperfusion injury
05/11/1995WO1995012389A1 Multilamellar liposomal arachidonic acid metabolite formulations
05/11/1995WO1995012388A1 Methods of treatment using unilamellar liposomal arachidonic acid metabolite formulations
05/11/1995CA2175896A1 Methods of treatment using unilamellar liposomal arachidonic acid metabolite formulations
05/11/1995CA2175692A1 Immunodominant human t-cell epitopes of hepatitis c virus
05/11/1995CA2175467A1 Use of nitric oxide releasing compounds as protective agents in ischemia reperfusion injury
05/11/1995CA2175057A1 Multilamellar liposomal arachidonic acid metabolite formulations
05/11/1995CA2174548A1 Process for the preparation of n-4-¬(substituted phenyl)alkylthienyl|-, and n-4-¬(substituted phenyl)alkylfuryl|but-3-yn-2-yl|-n-hydroxyurea compounds
05/11/1995CA2153146A1 Method for inhibiting intracellular viral replication
05/10/1995EP0652290A1 Method for regulation of NF-kB
05/10/1995EP0652231A1 NON-TOXIC RIBOSOME INACTIVATING PROTEINS (RIPs) WITH TWO CHAINS, PROCESS FOR THE PREPARATION THEREOF AND APPLICATIONS
05/10/1995EP0652228A1 Urethanes and ureas that induce cytokine production
05/10/1995EP0652214A1 N-Aryl-2-cyano-3-hydroxy propenamide derivatives, a method for their preparation, their use as medicaments and pharmaceutical compositions containing them
05/10/1995EP0652208A1 Phenylalkan(en)oic acids with leukotriene B4 antagonistic activity
05/10/1995EP0652010A1 Use of alphatocopherol acetate or a derivative for the preparation of cosmetic, dermatalogical or pharmaceutical compositions with anti radical activity
05/10/1995EP0651798A1 Target antigens of transmission blocking antibodies for malaria parsites
05/10/1995EP0651743A1 Indolinyl n-hydroxyurea and n-hydroxamic acid derivatives as lipoxygenase inhibitors
05/10/1995EP0651738A1 Natural amino acid derivatives as metalloproteinase inhibitors
05/10/1995EP0477231B1 Immunoactive peptides and antibodies and their use in anti-allergy treatment
05/10/1995CN1028367C Nonsaditive antihistaminics derived from benzimidazoles
05/09/1995US5413999 HIV protease inhibitors useful for the treatment of AIDS
05/06/1995CA2135000A1 Isoquinolines
05/05/1995CA2135044A1 N-aryl-2-cyano-3-hydroxypropenamides derivatives, proc ess for their preparation, their application as medicaments and pharmaceutical compositions containing them
05/04/1995WO1995011702A1 Prokaryotic expression of mhc proteins
05/04/1995WO1995011693A1 Hemoregulatory peptides
05/04/1995WO1995011687A1 Therapeutic use of cis-element decoys in vivo
05/04/1995WO1995011670A1 Liposomal defensins
05/04/1995WO1995011664A1 Method for preparing a viral aerosol
05/04/1995WO1995006728A3 T cell epitopes of ryegrass pollen allergen
05/04/1995WO1995006077A3 Polymeric matrices and their uses in pharmaceutical compositions
05/04/1995WO1994028132A3 Opioid receptors: compositions and methods
05/04/1995CA2175089A1 Prokaryotic expression of mhc proteins
05/03/1995EP0650727A1 Use of hydroxychloroquine for treatment of graft-versus-host disease
05/03/1995EP0650721A1 Cyclosporin soft capsule
05/03/1995EP0650498A1 Suppression of t-cell proliferation using peptide fragments of myelin basic protein
05/03/1995EP0650489A1 Rapamycin derivatives
05/03/1995EP0650485A1 2,5-diaryl tetrahydro-thiophenes, -furans and analogs for the treatment of inflammatory and immune disorders
05/03/1995EP0650371A1 Covalent polar lipid-peptide conjugates for biological targeting
05/03/1995EP0650363A1 Antiviral combinations
05/03/1995EP0650362A1 Antiviral combinations
05/03/1995EP0650357A1 Rapamycin derivatives
05/03/1995EP0650356A1 Rapamycin derivatives
05/03/1995EP0379522B1 Uses of recombinant colony stimulating factor-1
05/03/1995EP0327612B1 Pharmaceutical therapeutic use of glutathione derivatives
05/02/1995US5411971 N-alkylenepiperidino compounds, their enantiomers and pharmaceutical compositions
05/02/1995US5411960 Substituted pyrroloanthracenes and -diones
05/02/1995US5411952 Ocular cyclosporine composition
05/02/1995CA1335450C Indole and indazole keto sulphones as leukotriene antagonists
04/1995
04/27/1995WO1995011231A1 Amidino derivatives useful as nitric oxide synthase inhibitors
04/27/1995WO1995011039A1 PHARMACEUTICAL COMPOSITION CONTAINING CYCLOSPORINE A AND α-TOCOPHEROL
04/27/1995WO1995011014A1 Amidino derivatives useful as nitric oxide synthase inhibitors
04/27/1995CA2173468A1 Amidino derivatives useful as nitric oxide synthase inhibitors
04/27/1995CA2170735A1 Amidino derivatives useful as nitric oxide synthase inhibitors
04/26/1995EP0649651A1 Soft gelatin capsule manufacture
04/26/1995EP0649468A1 Soluble cr1 derivatives
04/26/1995EP0649418A1 7-(2-aminoethyl)-benzothiazolones
04/26/1995EP0649412A1 Pharmaceutical pyridine compounds
04/26/1995EP0649411A1 Boronated compounds
04/26/1995EP0649409A1 Vinyl arenas having retinoid-like activity
04/26/1995EP0649405A1 22-ene-25-oxa derivatives of the vitamin d series, method of preparing such derivatives, pharmaceutical preparations containing them and thus use of such preparations as drugs.
04/26/1995CN1101915A New 19-nor steroids having a phenoxyalkylsulphonamide or phenoxyalkylsulphonylurea chain in position llbeta, preparation process and intermediates, use as medicaments and pharmaceutical compositions..
04/25/1995USRE34918 Antihistamines, muscle relaxants
04/25/1995US5410061 Pharmaceutical compounds
04/25/1995US5409934 Xanthine derivatives
04/25/1995US5409899 Pseudopeptide compounds having anti-inflammatory activity
04/25/1995US5409895 Protease inhibitory polypeptides derived from urinary trypsin inhibitor and compositions thereof
04/25/1995US5409701 From flexibacter culture; human leukocyte elastase inhibitor
04/25/1995US5409698 Liposome immunoadjuvants containing IL-2
04/25/1995CA1335405C Oligosaccharides, immunogens and vaccines, and methods for preparing such oligosaccharides, immunogens and vaccines
04/20/1995WO1995010630A1 Tumor suppressor genes, proteins encoded thereby and use of said genes and proteins
04/20/1995WO1995010540A1 Fas antagonists and uses thereof
04/20/1995WO1995010539A1 Growth differentiation factor-10
04/20/1995WO1995010532A1 Compounds useful in anti-allergy treatment
04/20/1995WO1995010531A1 Oligopeptides derived from c-reactive protein fragments
04/20/1995WO1995010506A1 1n-alkyl-n-arylpyrimidinamines and derivatives thereof
04/20/1995WO1995010301A1 Immunological tolerance-inducing agent
04/20/1995WO1995010271A2 Phenylacetate and derivatives alone or in combination with other compounds against neoplastic conditions and other disorders
04/20/1995WO1995010265A1 Therapeutic delivery compositions and methods of use thereof
04/20/1995CA2174136A1 Tumor suppressor genes, proteins encoded thereby and use of said genes and proteins
04/20/1995CA2174132A1 Fas antagonists and uses thereof
04/20/1995CA2173856A1 Compounds useful in anti-allergy treatment
04/20/1995CA2172960A1 Treatment of allergic disorders with terfenadine carboxylate
04/20/1995CA2171546A1 Growth differentiation factor-10
04/20/1995CA2118454A1 Composition for inhibiting ige production
04/19/1995EP0648759A1 Antihistaminic compounds, process for their preparation and pharmaceutical compositions containing them
04/19/1995EP0648499A1 Composition for inhibiting IgE production
04/19/1995EP0648225A1 Compositions for the inhibition of protein hormone formation and uses thereof
04/19/1995EP0648209A1 Contrast agents for mr diagnosis
04/19/1995EP0648127A1 Type i and type ii surface antigens associated with staphylococcus epidermidis
04/19/1995EP0451299B1 Magnetocontrollable carrier with physiologically active substance and method for making said carrier
04/19/1995EP0407392B1 UNIQUE ANTIGENIC EPITOPES ON IgE-BEARING B LYMPHOCYTES
04/19/1995EP0243446B1 Alpha tocopherol-based vesicles
04/19/1995CN1028227C Pharmacologically active 1,5-diarly-3-substituted-pyrazoles and method for synthesizing the same
04/18/1995US5407961 α-substituted benzenemethanamine derivatives and pharmaceutical use
04/18/1995US5407923 Antiinflammatory agents
04/16/1995CA2118188A1 Antihistaminic compounds, process for their preparation and pharmaceutical compositions containing them
04/13/1995WO1995009921A1 Platelet-activating factor acetylhydrolase
04/13/1995WO1995009912A1 Stem cell proliferation factor
04/13/1995WO1995009868A1 Compounds modifying serotoninergic transmission, diagnostic and therapeutic applications
04/13/1995WO1995009857A1 O-aryl, o-alkyl, o-alkenyl and o-alkynyl-macrolides having immunosuppressive activity
1 ... 1071 1072 1073 1074 1075 1076 1077 1078 1079 1080 1081 1082 1083 1084 1085 1086 1087 1088 1089 1090 1091 ... 1172